Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00538759 · ClinicalTrials.gov registry record · Phase 2
Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
A Phase 2 study, sponsored by Minneapolis Heart Institute Foundation.
- Terminated
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT00538759 is a Phase 2 study that was terminated before completion, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 21 participants.
The verdict
NCT00538759, a Phase 2 study, was terminated before completion, sponsored by Minneapolis Heart Institute Foundation.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
The objective of the RADAR trial is to determine the impact of External Beam Radiation Therapy (EBRT) on aortic valve restenosis following successful percutaneous balloon aortic valvuloplasty (BAV) in elderly patients with severe calcific aortic stenosis.
Interventions
- OTHER Sham Control
- DEVICE External beam radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00538759
The ClinicalTrials.gov registry entry for NCT00538759 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Minneapolis Heart Institute Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Control is the first listed.
NCT00538759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00538759 about?
NCT00538759 is a clinical study titled "Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis". The objective of the RADAR trial is to determine the impact of External Beam Radiation Therapy (EBRT) on aortic valve restenosis following successful percutaneous balloon aortic valvuloplasty (BAV) in elderly patients with severe calcific aortic stenosis.
What is the current status of trial NCT00538759?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2007-09. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00538759?
The interventions under investigation include: Sham Control (OTHER), External beam radiation therapy (DEVICE).
Who is sponsoring clinical trial NCT00538759?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.